On Jan. 5, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The FDA announced its approval of the state of Florida for the agency’s drug importation program, which allows imports of prescription drugs from Canada if they reduce costs for U.S. consumers without imposing additional risks to the public (see 2009290018), the FDA said in a news release Jan. 5. Under the program, Florida still must submit more drug-specific information for FDA approval, test the drugs it seeks to import and relabel the drugs to be consistent with FDA requirements. The program was approved for two years from the date of the first importation, the FDA said.
On Jan. 4, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Jan. 3, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Jan. 2, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: